Phaos Technology Holdings (Cayman) Limited, an advanced microscopy company listed on the NYSE American under POAS, entered into a securities purchase agreement (share-sale contract) with High West Partners LLC on September 28, 2026. The agreement gives Phaos the right, but not the obligation, to sell up to US$10 million of Class A ordinary shares at prevailing market prices, subject to the agreement and applicable NYSE listing rules. The facility begins once the conditions for sales and the investor’s purchase obligations are satisfied and runs for 36 months from that Commencement Date. Phaos will also issue an unspecified number of Class A ordinary shares to High West Partners as a commitment fee, fully earned on the Commencement Date and delivered with the first purchase notice. The company said its microscopy products and artificial-intelligence-powered software serve manufacturing, biomedical and research applications. The release also contained standard forward-looking statements and risk disclosures under the U.S. Private Securities Litigation Reform Act of 1995.